Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study is conducted in a cohort of low dose aspirin (ASA) users previously ascertained
.The aims of the post hoc analyses are:
To estimate the one year risk of discontinuation of use of low-dose ASA associated to PPI
concomitant use versus non-use, crude and adjusted by confounding.
To estimate the one year risk of discontinuation of use of low-dose ASA associated to PPI
concomitant use stratified by age and sex.
To evaluate other predictors of discontinuation of low-dose ASA during the first year of ASA
therapy.